NCT00004831View on ClinicalTrials.gov

Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 1996

Study Completion Date

July 31, 1998

Conditions
Erythropoietic Protoporphyria
Interventions
DRUG

cysteine hydrochloride

All Listed Sponsors
collaborator

St. Luke's-Roosevelt Hospital Center

OTHER

lead

FDA Office of Orphan Products Development

FED

NCT00004831 - Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria | Biotech Hunter | Biotech Hunter